Forbes -
27 Jan 2014 19:47
The pharmaceutical business is getting increasingly important for Johnson & Johnson, as the growth in its bread and butter medical devices & diagnostics business stays flat. Additionally, the value contribution of consumer business remains small due to extremely low profit margins.
Share this Article
Comment on this Article
Please to comment